Mersana Therapeutics mersana.com


Public list: Smart Money VCs (6327) Pharma Startups (4733) Cancer Therapeutics (1136)

Mersana Therapeutics (NASDAQ: MRSN) is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. Its most advanced platform, Dolaflexin, has been used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not currently amenable to treatment with traditional ADC-based therapies. Mersana's product candidates include XMT...Show all

Mersana Therapeutics (NASDAQ: MRSN) is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. Its most advanced p...Show all

Company (IPO / Went public)

Phone: 617-498-0020

Fax:

840 Memorial Drive

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mersana Therapeutics $218M Jun 28, 2017
CombiMatrix $56.3M Nov 15, 2017
PTC Therapeutics $417.9M Jun 20, 2013
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mersana Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Protein-polymer-drug conjugates Jan 19, 2016 Apr 17, 2018 Patent
Hydroxyl-polymer-drug-protein conjugates Dec 12, 2013 Jan 23, 2018 Patent
Protein-polymer-drug conjugates Oct 10, 2014 Dec 26, 2017 Patent
Protein-polymer-drug conjugates and methods of using same Jun 18, 2015 Nov 07, 2017 Patent
Protein-polymer-drug conjugates Aug 24, 2015 Sep 26, 2017 Patent
See all 27 patents